Receptor Binding Kinetics: What Kd and EC50 Actually Mean
Dissociation constants, half-maximal effective concentrations, and why these numbers matter more than anecdotal reports when evaluating a peptide's research potential.
Mechanisms, protocols, and primary literature — everything a serious researcher needs to understand peptide science without the noise.
How peptides interact with receptors, enzymes, and intracellular signaling cascades. A foundational overview of binding kinetics, downstream pathway activation, and what in vitro data actually tells us.
Mechanism of action, key literature, and step-by-step bacteriostatic water reconstitution protocols for each compound.
Dissociation constants, half-maximal effective concentrations, and why these numbers matter more than anecdotal reports when evaluating a peptide's research potential.
A step-by-step breakdown of the growth hormone axis — GHRH receptor activation, somatotroph cell response, hepatic IGF-1 production, and feedback regulation.
The five melanocortin receptor subtypes, their tissue distribution, and how selective vs. non-selective agonists like MT-1, MT-2, and PT-141 interact with each.
How to interpret HPLC chromatograms, what peak area percentages represent, and why a 98% purity figure doesn't always mean what you think it means.
ESI-MS and MALDI-TOF explained for non-specialists. How mass spec confirms molecular identity, detects truncated sequences, and validates synthesis quality.
Fmoc vs. Boc chemistry, resin selection, coupling efficiency, and the steps between amino acid building blocks and a finished lyophilized peptide.
Bacteriostatic water vs. sterile water, optimal reconstitution volumes, freeze-thaw cycle effects, and storage conditions that maintain peptide stability over time.
Concentration ranges, vehicle selection, cell line considerations, and the controls needed to produce reproducible, interpretable in vitro peptide data.
Tube formation assays, scratch wound assays, and VEGF quantification — the standard in vitro toolkit for evaluating pro-angiogenic peptides like BPC-157.
A curated review of primary literature on BPC-157 — from Sikiric's foundational work to recent angiogenesis and gut healing studies. What's replicated, what isn't.
The evolution of GLP-1 receptor agonist research — receptor structure, incretin effect mechanisms, and what the clinical trial data on semaglutide and tirzepatide actually demonstrates.
Telomerase activation, telomere length measurement methods, and a critical look at the in vitro and animal model data supporting epithalon's proposed mechanisms.
Our team reviews inquiries from qualified researchers, academic institutions, and biotech professionals.